Rules and Regulations for Poster Submissions
The submission deadline is May 10, 2014.
Successful applications meet the following criteria:
- Value and relevance to family medicine
- Quality of research design, methodology, and scientific content
- No promotional, commercial, or ethical conflicts of interest
- Has met the requirements of the applicant's local institutional review board (approval or waiver)
Members of the Subcommittee on Assembly Scientific Program make final decisions about eligibility. The American Academy of Family Physicians (AAFP) reserves the right to deny any application that, in the opinion of the AAFP, is deemed promotional, commercial, or unethical.
If there is more than one author, the first author listed should be the primary author; that is, the person who has done the majority of work. This is the author upon whom the classification of the submission should be based. International attendee classifications are open to anyone who conducted clinical or educational research relevant to family medicine outside the United States. The classifications are as follows:
- Family medicine residents
- Medical students
- All material must be current, relevant, and free from ethical bias.
- Comparisons of efficacy, contraindications, modes of administration, etc., between competitive products should be fully presented.
- Editorial conclusions should be avoided.
- Any reference to a pharmaceutical product, medical device, or any product that is sold on the open market must not be promotional, and generic names must be used.
All submissions must include completion of an updated or new Full Disclosure for CME Activities form. Applicants will be contacted if any relationships are determined to represent a potential conflict of interest. Poster judging results are contingent upon receipt of all disclosure forms and resolutions of all existing conflicts of interest.
If financial support has been provided for the preparation of the poster, it must be indicated on the application form. The AAFP, as well as the Accreditation Council for Continuing Medical Education, requires all presenters to sign a disclosure statement indicating whether financial support was provided. The disclosure statement must be submitted with the application. Failure to disclose financial support will result in disqualification of the application.
Logos of the supporting company are prohibited on any part of the poster. Only generic names of drugs and other products may be used in the body of the poster. An asterisk may mark the first appearance of the generic name, with the trade name as a footnote at the bottom of the display not exceeding one-half inch in height. When a number of different products appear in the poster copy, exception to the rule may be granted at the discretion of the Subcommittee. All generic designations of competitive products shall be used with equal emphasis on height, weight, color, and typeface of lettering. The senior exhibitor shall be fully responsible for the content, arrangement, and presentation of all data in the poster. The AAFP may prohibit or remove any poster or material that, in the opinion of the AAFP, may detract from the general character of the poster presentations as a whole, or that consists of products or services inconsistent with the purpose of the poster presentations, without liability for any refunds or other poster expenses incurred.